Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Assessment of safety and efficacy of triple technique in managemnt of recurrent pterygium

Poster Details

First Author: A.Hasan EGYPT

Co Author(s):                        

Abstract Details


to assess the efficacy and safety of use of bivacizumab,mitomycin c and triamcinolon in management of recurrent pterygium


Sohag faculty of medicine ,Egypt


Fifteen eyes of fifteen patients with recurrent pterygium were injected by bivacizumab(1.25mg0.1ml) subconjunctivally after one week surgical excision with bare sclera technique , mitomycin c 0.1% application intraoperatively finally subtenon triamcinolon(8 mg 0.2 ml) was injected.follow up of the patients from 8 to36 months was done to detect recurrence or any other complications


Fifteen eyes of fifeen patients with recurrent pterygium of previous one surgery from 8 month to 12 years with mean 4.2 years 12 patients were males (80%) and 3 were females (20%) The recurrent pterygium ranging from 2mm to 5.5 mm from the limbus with mean 3.2 mm The follow up period from 8 month to 36 month with mean 25 months The complications were One patient with postoperative granuloma (6.7%) underwent excision after 21 days of surgey and resolved One patient(6.7%) with irritable eye with lacrimation and pain for one month resolved by frequent steroid No recurrence or major complications occurred in the follow up period


Triple technique is safe and effctive technique in management of recurrent pterygium

Financial Disclosure:


Back to Poster listing